Literature DB >> 31511992

Cognition and Cognitive Impairment in Migraine.

Raquel Gil-Gouveia1,2, Isabel Pavão Martins3,4.   

Abstract

BACKGROUND: Migraine is a complex neurological disorder that affects a significant percentage of the human species, from all geographic areas and cultures. Cognitive symptoms and dysfunctions are interim and disabling components of this disorder and may be related to the brain processes underlying the pathophysiology. Yet they are often undervalued by clinicians. In this review, we present the different types of cognitive dysfunctions associated with migraine and the mechanisms that are potentially causing them.
FINDINGS: While reversible attack-related cognitive dysfunction seems extremely consistent and likely related to functional cortical and subcortical brain changes occurring during attacks, interictal cognitive dysfunction is less consistent and might become more relevant as attack frequency and disease complexity increase. Migraine traits do not seem a predisposition to long-term cognitive decline. Cognitive dysfunction is a frequent manifestation of migraine attacks and may be specific to this disorder; it is important to understand if it could be useful in migraine diagnosis. Attack-related cognitive dysfunction is clinically relevant and contributes to disability, so it should be perceived as a therapeutic target. While there is no evidence to support that migraine increases the risk of long-term or persistent cognitive dysfunction, the fact that it occurs during the attacks and may persist in subjects with frequent or complicated attacks should prompt the understanding of the mechanisms related to its pathophysiology for it may also clarify the processes underlying migraine.

Entities:  

Keywords:  Attention; Brain imaging; Cognitive complaints; Cognitive decline; Executive functions; Migraine; Migraine attacks

Mesh:

Year:  2019        PMID: 31511992     DOI: 10.1007/s11916-019-0824-7

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  96 in total

Review 1.  Cortical excitability in chronic migraine.

Authors:  Gianluca Coppola; Jean Schoenen
Journal:  Curr Pain Headache Rep       Date:  2012-02

2.  Cognitive development in children with migraine and their healthy unaffected siblings.

Authors:  F Haverkamp; A Hönscheid; K Müller-Sinik
Journal:  Headache       Date:  2002-09       Impact factor: 5.887

3.  Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition.

Authors: 
Journal:  Cephalalgia       Date:  2018-01       Impact factor: 6.292

4.  Accurate Classification of Chronic Migraine via Brain Magnetic Resonance Imaging.

Authors:  Todd J Schwedt; Catherine D Chong; Teresa Wu; Nathan Gaw; Yinlin Fu; Jing Li
Journal:  Headache       Date:  2015-06       Impact factor: 5.887

5.  Frontal lobe dysfunction in patients with chronic migraine: a clinical-neuropsychological study.

Authors:  Franco Mongini; Roberto Keller; Andrea Deregibus; Erica Barbalonga; Tullia Mongini
Journal:  Psychiatry Res       Date:  2005-01-30       Impact factor: 3.222

6.  Migraine is associated with better cognition in the middle-aged and elderly: the Rotterdam Study.

Authors:  K Wen; N T Nguyen; A Hofman; M A Ikram; O H Franco
Journal:  Eur J Neurol       Date:  2016-06-27       Impact factor: 6.089

7.  Cognitive impairment in patients with severe migraine.

Authors:  C Zeitlin; M Oddy
Journal:  Br J Clin Psychol       Date:  1984-02

8.  Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization.

Authors:  Rami Burstein; Moshe Jakubowski
Journal:  Ann Neurol       Date:  2004-01       Impact factor: 10.422

9.  Frontal lobe structure and executive function in migraine patients.

Authors:  Nicole Schmitz; Enrico B Arkink; Marieke Mulder; Katya Rubia; Faiza Admiraal-Behloul; Guus G Schoonman; Mark C Kruit; Michel D Ferrari; Mark A van Buchem
Journal:  Neurosci Lett       Date:  2008-05-16       Impact factor: 3.046

Review 10.  Fear and the Defense Cascade: Clinical Implications and Management.

Authors:  Kasia Kozlowska; Peter Walker; Loyola McLean; Pascal Carrive
Journal:  Harv Rev Psychiatry       Date:  2015 Jul-Aug       Impact factor: 3.732

View more
  8 in total

1.  Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study.

Authors:  Cecilia Rustichelli; Elisa Bellei; Stefania Bergamini; Emanuela Monari; Flavia Lo Castro; Carlo Baraldi; Aldo Tomasi; Anna Ferrari
Journal:  J Headache Pain       Date:  2021-03-23       Impact factor: 7.277

2.  Attention Impairment During the Interictal State in Migraineurs without Aura: A Cross-Sectional Study.

Authors:  Cheng Chen; Xin Dong; Ping Gu; Keyan Chen; Qi Wan; Haiyue Xie; Zhaochun Shi; Teng Wang
Journal:  J Pain Res       Date:  2021-10-06       Impact factor: 3.133

Review 3.  Cognitive Impairment in Primary and Secondary Headache Disorders.

Authors:  Olivia Begasse de Dhaem; Matthew S Robbins
Journal:  Curr Pain Headache Rep       Date:  2022-03-03

Review 4.  Cerebro-Cerebellar Networks in Migraine Symptoms and Headache.

Authors:  Rodrigo Noseda
Journal:  Front Pain Res (Lausanne)       Date:  2022-07-13

5.  Preventive treatment can reverse cognitive impairment in chronic migraine.

Authors:  Cristina González-Mingot; Anna Gil-Sánchez; Marc Canudes-Solans; Silvia Peralta-Moncusi; Maria José Solana-Moga; Luis Brieva-Ruiz
Journal:  J Headache Pain       Date:  2022-09-15       Impact factor: 8.588

Review 6.  Migraine Is More Than Just Headache: Is the Link to Chronic Fatigue and Mood Disorders Simply Due to Shared Biological Systems?

Authors:  Nazia Karsan; Peter J Goadsby
Journal:  Front Hum Neurosci       Date:  2021-06-03       Impact factor: 3.169

Review 7.  Headache in Children and Adolescents.

Authors:  Christina Szperka
Journal:  Continuum (Minneap Minn)       Date:  2021-06-01

8.  Premonitory symptoms in glyceryl trinitrate triggered migraine attacks: a case-control study.

Authors:  Gerrit L J Onderwater; Jitze Dool; Michel D Ferrari; Gisela M Terwindt
Journal:  Pain       Date:  2020-09-01       Impact factor: 7.926

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.